DMK Pharmaceuticals Corporation
CY3B
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.66M | 640.30K | 3.10M | 1.08M | 2.42M |
| Total Receivables | -- | 19.00K | 21.20K | 1.09M | 1.55M |
| Inventory | 663.00K | 664.40K | 664.40K | 1.24M | 1.09M |
| Prepaid Expenses | 472.60K | 609.80K | 744.40K | 990.10K | 803.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 72.60K | 1.52M | 3.02M | 4.88M | 4.22M |
| Total Current Assets | 7.87M | 3.45M | 7.55M | 9.27M | 10.09M |
|
|
|||||
| Total Current Assets | 7.87M | 3.45M | 7.55M | 9.27M | 10.09M |
| Net Property, Plant & Equipment | 1.08M | 1.29M | 1.48M | 1.61M | 2.00M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.70K | 9.70K | 52.20K | 52.20K | 52.20K |
| Total Assets | 8.96M | 4.75M | 9.08M | 10.93M | 12.14M |
|
|
|||||
| Total Accounts Payable | 9.97M | 11.37M | 9.78M | 7.94M | 5.30M |
| Total Accrued Expenses | 2.32M | 2.20M | 1.83M | 1.51M | 1.34M |
| Short-term Debt | -- | 175.20K | 130.20K | 305.80K | 408.10K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 63.20K | 157.20K | 250.40K | 342.60K | 368.80K |
| Total Finance Division Other Current Liabilities | 1.10M | 1.11M | 957.50K | 1.30M | 1.46M |
| Total Other Current Liabilities | 1.10M | 1.11M | 957.50K | 1.30M | 1.46M |
| Total Current Liabilities | 13.46M | 15.01M | 12.95M | 11.40M | 8.87M |
|
|
|||||
| Total Current Liabilities | 13.46M | 15.01M | 12.95M | 11.40M | 8.87M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 175.20K | 130.20K | 305.80K | 408.10K |
| Capital Leases | -- | -- | -- | -- | 63.20K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 459.60K | 1.24M | 5.65M | 185.70K | 197.20K |
| Total Liabilities | 13.92M | 16.24M | 18.60M | 11.58M | 9.13M |
|
|
|||||
| Common Stock & APIC | 318.18M | 310.26M | 303.83M | 303.76M | 304.09M |
| Retained Earnings | -323.47M | -322.08M | -313.51M | -304.56M | -301.24M |
| Treasury Stock & Other | -5.30K | -5.30K | -5.30K | -5.30K | -5.30K |
| Total Common Equity | -5.29M | -11.83M | -9.68M | -808.10K | 2.85M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 330.00K | 330.00K | 157.30K | 157.30K | 157.30K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 330.00K | 330.00K | 157.30K | 157.30K | 157.30K |
|
|
|||||
| Total Common Equity | -5.29M | -11.83M | -9.68M | -808.10K | 2.85M |
| Total Preferred Equity | 330.00K | 330.00K | 157.30K | 157.30K | 157.30K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.96M | -11.50M | -9.52M | -650.80K | 3.00M |
|
|
|||||